Vensica Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
3

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$19M
- Investors
-
9
Vensica General Information
Description
Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system leverages the known properties of ultrasound, is needle-free, and is expected to not have any side effects, enabling medical professionals to safely and effectively deliver treatment to patients suffering from urinary overactive bladder.
Contact Information
Website
www.vensica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Primary Office
- HaGavish Street 4
- Netanya 4250706
- Israel
+972 000-000-0000
Vensica Timeline
Vensica Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 01-Nov-2021 | $19M | 000.00 | Completed | Generating Revenue | |
4. Corporate | 11-Aug-2021 | 00.00 | Completed | Generating Revenue | ||
3. Corporate | 02-Oct-2017 | 000 | 00.00 | Completed | Generating Revenue | |
2. Angel (individual) | 19-Jul-2016 | $500K | $500K | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Startup |
Vensica Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system l
Drug Delivery
Netanya, Israel
3
As of 2022
000.00
0000000000 0
000.00
Vensica Competitors (14)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Urogen Pharma | Formerly VC-backed | Princeton, NJ | 000 | 00000 | 000000000 | 00000 |
0000000000 | Venture Capital-Backed | Milan, Italy | 00 | 000.00 | 00000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | Kirkland, WA | 00 | 00000 | 00000000000 | 00000 |
00000000 (00000000 | Venture Capital-Backed | Paris, France | 00 | 0000 | 00000000000 | 0000 |
000000000 00000000 | Private Equity-Backed | Irvine, CA | 000 | 00000 | 0000000 0000 | 00000 |
Vensica Patents
Vensica Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210052873-A1 | System and method for ultrasonic bladder therapeutic agent delivery | Active | 01-Apr-2018 | 000000000 | |
US-11529506-B2 | System and method for ultrasonic bladder therapeutic agent delivery | Active | 01-Apr-2018 | 000000000 | 00 |
EP-3773262-A1 | System and method for ultrasonic bladder therapeutic agent delivery | Pending | 01-Apr-2018 | 00000000000 | |
AU-2019249430-A1 | System and method for ultrasonic bladder therapeutic agent delivery | Pending | 01-Apr-2018 | 00000000000 | |
CA-3095598-A1 | System and method for ultrasonic bladder therapeutic agent delivery | Pending | 01-Apr-2018 | A61M37/0092 |
Vensica Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Avner Geva | Founder & Chief Executive Officer |
Vensica Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Edit Goldberg | Self | Board Member | 000 0000 |
Eran Feldhay MD | Trendlines | Board Member | 000 0000 |
Nissim Darvish Ph.D | Self | Chairman | 000 0000 |
Vensica Signals
Vensica Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Agriline | Corporation | Minority | 000 0000 | 000000 0 | |
Israel Biotech Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
Merz Pharma | Corporation | Minority | 000 0000 | 000000 0 | |
Cogentix Medical | PE-Backed Company | Minority | 000 0000 | 000000 0 | |
Israel Innovation Authority | Government | Minority | 000 0000 | 000000 0 |